Pfizer, Biohaven

Pfizer agrees ~$60 million false claims settlement over Nurtec ODT
The US Department of Justice announced Friday that Pfizer has agreed in New York federal court to pay $59.7 million to resolve allegations that one of its subsidiaries caused false Medicare claims by paying kickbacks to physicians.
Pfizer settles Biohaven kickback claims case for $59.7m
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
Pfizer settles Biohaven kickback case with DOJ for $60M
Pfizer (PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to induce prescriptions for its migraine drug Nurtec ODT. Read more here.
Pfizer Settles $59.7M Medicare Kickback Case Over Biohaven Practices
Pfizer (NYSE:PFE) has agreed to pay $59.7 million to resolve allegations that Biohaven Pharmaceuticals, acquired by Pfizer in October 2022, defrauded Medicare and other healthcare programs by offering kickbacks to
Pfizer to Pay $60 Million in Kickback, False Claims Settlement
Pfizer will pay $60 million to settle allegations that one of its subsidiaries incentivized healthcare providers to prescribe one of its drugs, resulting in the submission of false claims to federal healthcare programs.
Pfizer to pay $60 million to settle claims that Biohaven paid kickbacks to doctors
The alleged violations occurred before Pfizer bought Biohaven and its migraine treatment three years ago for $11.6 billion.
The past three years for Pfizer (NYSE:PFE) investors has not been profitable
For many investors, the main point of stock picking is to generate higher returns than the overall market. But if ...
The Pharma Letter6h
Positive Phase III results for Pfizer’s Braftovi combo
US pharma giant Pfizer on Saturday announced positive results from the Phase III BREAKWATER trial evaluating its Braftovi ...
Pfizer succeeds in late-stage trial for colorectal cancer therapy
Pfizer (PFE) colorectal cancer therapy Braftovi as part of a drug combo indicates a favorable objective response rate in a ...
Is Pfizer Inc. (PFE) the Best Stock to Invest In For Steady Dividends?
We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...
Zacks Research Issues Positive Outlook for Pfizer Earnings
Equities research analysts at Zacks Research upped their Q1 2026 earnings per share estimates for Pfizer in a report released ...
Pfizer (NYSE:PFE) Is Paying Out A Larger Dividend Than Last Year
Pfizer Inc. ( NYSE:PFE ) will increase its dividend from last year's comparable payment on the 7th of March to ...